NYSE · BDX

Becton, Dickinson and Company

Healthcare · Medical - Instruments & Supplies

$180.94

Down-$0.44 (-0.24%)

Updated Sep 20, 2026, 11:41 AM

SID Score

5.8/10

Composite research score

Smart Money

58/100

Neutral

Market cap: 57.44B
P/E ratio: 34.23
Dividend yield: 2.30%
52-week range: $140.11 – $213.08
Volume: 6.42M
Avg. volume: 1.98M

Price performance

BDX price history

1M range · 19 trading sessions · Daily adjusted prices

Last close: $180.94
Period change: -5.14%
Period low: $176.42
Period high: $190.74

Daily close

View OHLC price history

BDX OHLC price history, latest 40 sessions
Date	Open	High	Low	Close	Volume
Sep 18, 2026	$179.76	$182.615	$179.42	$180.94	6.42M
Sep 17, 2026	$182.71	$184.34	$181.27	$181.38	1.84M
Sep 16, 2026	$185.18	$186.27	$181.29	$181.85	1.73M
Sep 15, 2026	$182.39	$186.63	$181.28	$185.92	2.09M
Sep 14, 2026	$180.05	$183.53	$179.60	$182.91	1.63M
Sep 11, 2026	$177.60	$178.30	$175.20	$177.85	1.58M
Sep 10, 2026	$178.94	$178.94	$175.67	$176.42	1.71M
Sep 9, 2026	$177.15	$182.10	$176.55	$179.80	1.53M
Sep 8, 2026	$181.75	$182.20	$178.47	$179.10	1.81M
Sep 4, 2026	$185.42	$187.13	$184.05	$184.74	1.44M
Sep 3, 2026	$188.97	$189.47	$184.91	$187.62	1.21M
Sep 2, 2026	$187.43	$191.755	$187.43	$187.52	1.47M
Sep 1, 2026	$190.30	$191.57	$186.48	$187.12	1.28M
Aug 31, 2026	$187.88	$188.97	$186.62	$188.11	2.63M
Aug 28, 2026	$188.04	$190.32	$187.5375	$189.52	1.69M
Aug 27, 2026	$189.29	$190.41	$187.73	$188.13	1.35M
Aug 26, 2026	$188.49	$191.52	$188.02	$190.21	1.4M
Aug 25, 2026	$189.31	$190.07	$187.03	$189.78	1.21M
Aug 24, 2026	$191.73	$193.07	$190.35	$190.74	1.31M

Latest BDX news

The latest Smart Investors Daily articles mentioning BDX.

analystAug 14, 2026

RBC Capital Reiterates Sector Perform Rating on Becton, Dickinson and Company (BDX)

institutionalAug 6, 2026

First Eagle Investment Management, LLC Initiates New Position in Becton, Dickinson and Company (BDX)

institutionalJul 29, 2026

GREENHAVEN ASSOCIATES INC Initiates New Position in Becton, Dickinson and Company (BDX)

Latest BDX news

The latest Smart Investors Daily articles mentioning BDX.

Stock researchCompany · Overview

Company

Overview Forecast Earnings Dividend Financials

Market Activity

Options Insider Trades Short Interest Institutional Ownership Sentiment

Research & News

Analysis Competitors News SEC Filings SID Coverage

BDX research

Overview

Company profile and research snapshot.

Company profile

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus: Buy
Average target: $210.00
Implied upside: —
Analysts: 15

BDX recent ratings
Date	Firm	Rating	Target
Aug 31, 2026	B of A Securities	Neutral	—
Aug 13, 2026	RBC Capital	Sector Perform	—
Aug 7, 2026	Piper Sandler	Neutral	—
Aug 7, 2026	RBC Capital	Sector Perform	—
Aug 7, 2026	Wells Fargo	Equal-Weight	—

Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 14, 2026

BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Fairview Health Services has become the first health system in the United States to deploy the BD Vmax 160, a next generation pharmacy automation robot designed to help health systems manage the increasing complexity of specialty therapies and refrigerated medicines in high-volume, centralized outpatient pharmacy operations.

Yahoo · Sep 9, 2026

BSX Stock: Is It Time To Buy Or Sell Puts?

Trading near $45 a share, Boston Scientific (BSX) sits roughly 58% below its 52-week peak. Instead of buying the dip outright, selling cash-secured put options allows investors to generate immediate income while locking in an even deeper entry point. Sell a put option on BSX expiring 9/17/2027, with a strike price of $30.

SeekingAlpha · Sep 9, 2026